RT Journal Article
SR Electronic
T1 Investigation of intra-subtype recombination in Zimbabwean HIV 1 subtype C using bioinformatics. (December 2019)
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.10.29.22281702
DO 10.1101/2022.10.29.22281702
A1 Milton S Kambarami
A1 Manasa Justen
YR 2022
UL http://medrxiv.org/content/early/2022/11/01/2022.10.29.22281702.abstract
AB Intra-subtype recombination is a common phenomenon among HIV strains which involves transfer of genetic information between two viral strains belonging to the same HIV subtype. However, more research has been done on inter-subtype recombination which is the transfer of genetic information between two strains belonging to different HIV subtypes. In this study HIV 1 subtype C env sequences from Zimbabwean nucleotide sequences (n=2 915) downloaded from Los Alamos HIV databases were used to investigate intra-subtype recombination. Using the GENECUTTER tool, ∼44.4% of whole genomes were selected to have informative env regions (n = 1 295). Clustal was used for Multiple Sequence Alignment and RDP 4 was used for analysis and detection of Intra-subtype recombination. Apparently, GENECONV included in RDP 4 detected 47 recombination events. One of the most informative recombination events was further analysed using UPGMA phylogenetic tree to understand the extent of the intra-subtype recombination.Competing Interest StatementThe authors have declared no competing interest.Funding StatementHuman Hereditary and Health in Africa Bioinformatics Network (H3ABioNet)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used in present study are available upon reasonable request to the authors.